BRIGHT-4 trial: bivalirudin strikes back - Authors' reply. Li Y, Liang Z, Stone GW, Han Y, et al. Lancet 2023;401:1158.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li Y, Liang Z, Stone GW, Han Y, et al. BRIGHT-4 trial: bivalirudin strikes back - Authors' reply. Lancet 2023;401:1158.
PMID: 37030890